Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience

IntroductionRituximab (RTX) is considered a potential therapeutic option for relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). The main objective of this work was to investigate the effectiveness and safety of rituximab in MS.Patients and methodsObservational multice...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Francisco Gascón-Giménez, Carmen Alcalá, Lluís Ramió-Torrentà, Paloma Montero, Jorge Matías-Guiu, Irene Gómez-Estevez, Celia Oreja-Guevara, Sara Gil-Perotín, Yolanda Blanco, María Carcelén, Carlos Quintanilla-Bordás, Lucienne Costa, Luisa Maria Villar, Jose Enrique Martínez-Rodriguez, José Andrés Domínguez, Carmen Calles, Inés González, Javier Sotoca, Agustin Oterino, Celia Lucas-Jimenez, Francisco Pérez-Miralles, Bonaventura Casanova
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2023-03-01
Serier:	Frontiers in Neurology
Fag:	multiple sclerosis relapsing-remitting multiple sclerosis progressive multiple sclerosis treatment rituximab anti-CD20 monoclonal antibody
Online adgang:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1060696/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!